Norah A AlShehri

Family and Community Medicine Department, College of Medicine, King Saud University, Riyadh, Saudi Arabia

Publications

• Research   
  Association between Combined Hormonal Contraception Use and Deep Vein Thrombosis in Dyslipidemic Patients
  Author(s): Njoud F AlFaisal* and Norah A AlShehri
  
  Background: The risk of Deep Vein Thrombosis (DVT) and Combined Hormonal Contraception (CHC) use is well established in the literature in women of childbearing age. CHC has an estrogen component with a pro-thrombotic effect and progestin which can alter the lipid profile. There is controversy regarding the safety of CHC use in patients with dyslipidemia in terms of DVT. Thus, the association between CHC use and DVT risk in women with dyslipidemia needs to be reviewed. Objectives: This study aimed to assess the risk of DVT in women with dyslipidemia who were exposed to combined hormonal contraception compared to non-exposed women; to identify which CHC type carries the most DVT risk and to determine the association between CHC and lipid profile. Methods: Using a matched casecontrol study, we screened all women aged 18-79 years diagnosed with DVT in King Khalid University Hospital betwe.. Read More»
  DOI: O

  Abstract HTML PDF